Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Sidoti in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $43.00 price objective on the stock. Sidoti’s price objective points to a potential upside of 2.09% from the company’s current price. Other equities […]
Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Lake Street Capital in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $43.00 target price on the stock. Lake Street Capital’s price target points to a potential upside of 2.14% from the company’s […]
ASX Health Stocks: EMV s AI algorithm shows promise; Telix submits new FDA application theaustralian.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theaustralian.com.au Daily Mail and Mail on Sunday newspapers.
On 21 May 2024, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published a statement of policy intent (the Statement) setting out its proposals for international recognition.
BIOMEDevice Rebrands as MEDevice, Informa Markets - Engineering s Dedicated pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.